Global private equity and venture capital news and research

Hony Capital eyes $260m from another CSPC Pharmaceutical share sale

10 Oct 2013

lab glass biotech pharma chemicalChinese private equity firm Hony Capital is reportedly aiming to make about $260m by selling shares in CSPC Pharmaceutical Group through two affiliates.

Jinling Investment and Joyful Horizon are offering 500 million shares in the Chinese vitamin maker according to Bloomberg, which said it had obtained a term sheet detailing the deal.

Morgan Stanley is said to be arranging the transaction.

Earlier this year Bloomberg reported that Hony had raised about $155m selling CSPC shares.

Last year Beijing-based Hony, the private equity arm of Legend Holdings, raised nearly $4bn from LPs for two separate investment funds.

The Chinese firm raised almost $2.4bn for its fifth dollar-denominated fund and RMB10bn ($1.58bn) for its second renminbi-denominated investment vehicle, the firm said in a statement.

Both funds are more than double the size of their respective predecessors.

Copyright © 2013 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016